$RETA Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in REATA PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in REATA PHARMACEUTICALS INC. Get notifications about new insider transactions in REATA PHARMACEUTICALS INC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 14 2021 | RETA | REATA PHARMACEUTIC ... | Ruff Shamim | Director | Option Exercise | A | 146.01 | 780 | 113,888 | 780 | |
Jun 14 2021 | RETA | REATA PHARMACEUTIC ... | Ruff Shamim | Director | Option Exercise | A | 146.01 | 5,000 | 730,050 | 5,000 | |
Jun 14 2021 | RETA | REATA PHARMACEUTIC ... | Nielsen Jack | Director | Option Exercise | A | 146.01 | 1,201 | 175,358 | 1,201 | |
Jun 14 2021 | RETA | REATA PHARMACEUTIC ... | Nielsen Jack | Director | Option Exercise | A | 146.01 | 5,000 | 730,050 | 5,000 | |
Apr 16 2021 | RETA | REATA PHARMACEUTIC ... | Ruff Shamim | Director | Option Exercise | A | 92.20 | 319 | 29,412 | 319 | |
Apr 16 2021 | RETA | REATA PHARMACEUTIC ... | Ruff Shamim | Director | Option Exercise | A | 92.20 | 10,000 | 922,000 | 10,000 | |
Apr 16 2021 | RETA | REATA PHARMACEUTIC ... | Ruff Shamim | Director | Option Exercise | A | 92.20 | 1,250 | 115,250 | 1,250 | |
Apr 16 2021 | RETA | REATA PHARMACEUTIC ... | Oliger Christy J. | Director | Option Exercise | A | 92.20 | 106 | 9,773 | 106 | |
Apr 16 2021 | RETA | REATA PHARMACEUTIC ... | Oliger Christy J. | Director | Option Exercise | A | 92.20 | 10,000 | 922,000 | 10,000 | |
Apr 16 2021 | RETA | REATA PHARMACEUTIC ... | Oliger Christy J. | Director | Option Exercise | A | 92.20 | 1,250 | 115,250 | 1,250 | |
Jan 06 2021 | RETA | REATA PHARMACEUTIC ... | WORTLEY MICHAEL D | Chief Legal Officer | Option Exercise | A | 121.29 | 16,500 | 2,001,285 | 16,500 | |
Jan 06 2021 | RETA | REATA PHARMACEUTIC ... | WORTLEY MICHAEL D | Chief Legal Officer | Option Exercise | A | 121.29 | 16,500 | 2,001,285 | 16,500 | |
Jan 06 2021 | RETA | REATA PHARMACEUTIC ... | Soni Manmeet Singh | COO and CFO | Option Exercise | A | 121.29 | 24,000 | 2,910,960 | 24,000 | |
Jan 06 2021 | RETA | REATA PHARMACEUTIC ... | Huff James Warren | Chief Executive Off ... | Option Exercise | A | 121.29 | 44,600 | 5,409,534 | 44,600 | |
Jan 06 2021 | RETA | REATA PHARMACEUTIC ... | Castellanos Elaine | VP, Chief Accountin ... | Option Exercise | A | 121.29 | 8,000 | 970,320 | 8,000 | |
Dec 29 2020 | RETA | REATA PHARMACEUTIC ... | McGaughy R Kent Jr | Sell | J | 0.00 | 166,666 | 0 | 2,896,901 | 3.1 M to 2.9 M (-5.44 %) | |
Dec 29 2020 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Sell | J | 0.00 | 103,185 | 0 | 0 | 103.2 K to 0 (-100.00 %) | |
Dec 29 2020 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Sell | J | 0.00 | 63,481 | 0 | 0 | 63.5 K to 0 (-100.00 %) | |
Nov 19 2020 | RETA | REATA PHARMACEUTIC ... | Castellanos Elaine | VP, Chief Accountin ... | Gift | G | 0.00 | 600 | 0 | 14,546 | 15.1 K to 14.5 K (-3.96 %) |
Nov 18 2020 | RETA | REATA PHARMACEUTIC ... | Meyer Colin John | Chief Research Offi ... | Option Exercise | C | 0.00 | 6,395 | 0 | 59,779 | |
Nov 18 2020 | RETA | REATA PHARMACEUTIC ... | Meyer Colin John | Chief Research Offi ... | Option Exercise | M | 0.00 | 6,395 | 0 | 66,174 | |
Nov 18 2020 | RETA | REATA PHARMACEUTIC ... | Meyer Colin John | Chief Research Offi ... | Option Exercise | M | 11.00 | 6,395 | 70,345 | 88,636 | |
Nov 18 2020 | RETA | REATA PHARMACEUTIC ... | Meyer Colin John | Chief Research Offi ... | Option Exercise | C | 0.00 | 18,605 | 0 | 59,779 | |
Nov 18 2020 | RETA | REATA PHARMACEUTIC ... | Meyer Colin John | Chief Research Offi ... | Option Exercise | M | 0.00 | 18,605 | 0 | 78,384 | |
Nov 18 2020 | RETA | REATA PHARMACEUTIC ... | Meyer Colin John | Chief Research Offi ... | Option Exercise | M | 11.00 | 18,605 | 204,655 | 95,031 | |
Nov 18 2020 | RETA | REATA PHARMACEUTIC ... | Meyer Colin John | Chief Research Offi ... | Sell | S | 170.59 | 200 | 34,118 | 72,000 | 72.2 K to 72 K (-0.28 %) |
Nov 18 2020 | RETA | REATA PHARMACEUTIC ... | Meyer Colin John | Chief Research Offi ... | Sell | S | 166.14 | 1,930 | 320,643 | 72,200 | 74.1 K to 72.2 K (-2.60 %) |
Nov 18 2020 | RETA | REATA PHARMACEUTIC ... | Meyer Colin John | Chief Research Offi ... | Sell | S | 165.25 | 1,815 | 299,922 | 74,130 | 75.9 K to 74.1 K (-2.39 %) |
Nov 18 2020 | RETA | REATA PHARMACEUTIC ... | Meyer Colin John | Chief Research Offi ... | Sell | S | 164.44 | 2,450 | 402,888 | 75,945 | 78.4 K to 75.9 K (-3.13 %) |
Nov 18 2020 | RETA | REATA PHARMACEUTIC ... | Meyer Colin John | Chief Research Offi ... | Buy | C | 0.00 | 6,395 | 0 | 78,395 | 72 K to 78.4 K (+8.88 %) |
Nov 18 2020 | RETA | REATA PHARMACEUTIC ... | Meyer Colin John | Chief Research Offi ... | Sell | S | 175.00 | 100 | 17,500 | 72,000 | 72.1 K to 72 K (-0.14 %) |
Nov 18 2020 | RETA | REATA PHARMACEUTIC ... | Meyer Colin John | Chief Research Offi ... | Sell | S | 174.98 | 200 | 34,996 | 72,100 | 72.3 K to 72.1 K (-0.28 %) |
Nov 18 2020 | RETA | REATA PHARMACEUTIC ... | Meyer Colin John | Chief Research Offi ... | Sell | S | 173.75 | 100 | 17,375 | 72,300 | 72.4 K to 72.3 K (-0.14 %) |
Nov 18 2020 | RETA | REATA PHARMACEUTIC ... | Meyer Colin John | Chief Research Offi ... | Sell | S | 172.61 | 2,207 | 380,943 | 72,400 | 74.6 K to 72.4 K (-2.96 %) |
Nov 18 2020 | RETA | REATA PHARMACEUTIC ... | Meyer Colin John | Chief Research Offi ... | Sell | S | 171.38 | 3,824 | 655,367 | 74,607 | 78.4 K to 74.6 K (-4.88 %) |
Nov 18 2020 | RETA | REATA PHARMACEUTIC ... | Meyer Colin John | Chief Research Offi ... | Sell | S | 170.48 | 12,174 | 2,075,397 | 78,431 | 90.6 K to 78.4 K (-13.44 %) |
Nov 18 2020 | RETA | REATA PHARMACEUTIC ... | Meyer Colin John | Chief Research Offi ... | Buy | C | 0.00 | 18,605 | 0 | 90,605 | 72 K to 90.6 K (+25.84 %) |
Nov 13 2020 | RETA | REATA PHARMACEUTIC ... | McClellan William D. Jr. | Director | Option Exercise | C | 0.00 | 4,000 | 0 | 0 | |
Nov 13 2020 | RETA | REATA PHARMACEUTIC ... | McClellan William D. Jr. | Director | Option Exercise | M | 0.00 | 4,000 | 0 | 4,000 | |
Nov 13 2020 | RETA | REATA PHARMACEUTIC ... | McClellan William D. Jr. | Director | Option Exercise | M | 25.52 | 4,000 | 102,080 | 2,000 | |
Nov 13 2020 | RETA | REATA PHARMACEUTIC ... | McClellan William D. Jr. | Director | Sell | S | 174.82 | 488 | 85,312 | 0 | 488 to 0 (-100.00 %) |
Nov 13 2020 | RETA | REATA PHARMACEUTIC ... | McClellan William D. Jr. | Director | Sell | S | 173.22 | 970 | 168,018 | 488 | 1.5 K to 488 (-66.53 %) |
Nov 13 2020 | RETA | REATA PHARMACEUTIC ... | McClellan William D. Jr. | Director | Sell | S | 172.44 | 2,542 | 438,338 | 1,458 | 4 K to 1.5 K (-63.55 %) |
Nov 13 2020 | RETA | REATA PHARMACEUTIC ... | McClellan William D. Jr. | Director | Buy | C | 0.00 | 4,000 | 0 | 4,000 | 0 to 4 K |
Nov 13 2020 | RETA | REATA PHARMACEUTIC ... | Castellanos Elaine | VP, Chief Accountin ... | Option Exercise | C | 0.00 | 3,500 | 0 | 0 | |
Nov 13 2020 | RETA | REATA PHARMACEUTIC ... | Castellanos Elaine | VP, Chief Accountin ... | Option Exercise | M | 0.00 | 3,500 | 0 | 3,500 | |
Nov 13 2020 | RETA | REATA PHARMACEUTIC ... | Castellanos Elaine | VP, Chief Accountin ... | Option Exercise | M | 11.00 | 3,500 | 38,500 | 2,934 | |
Nov 13 2020 | RETA | REATA PHARMACEUTIC ... | Castellanos Elaine | VP, Chief Accountin ... | Sell | S | 176.02 | 3,500 | 616,070 | 15,146 | 18.6 K to 15.1 K (-18.77 %) |
Nov 13 2020 | RETA | REATA PHARMACEUTIC ... | Castellanos Elaine | VP, Chief Accountin ... | Buy | C | 0.00 | 3,500 | 0 | 18,646 | 15.1 K to 18.6 K (+23.11 %) |
Nov 12 2020 | RETA | REATA PHARMACEUTIC ... | WORTLEY MICHAEL D | Chief Legal Officer | Option Exercise | C | 0.00 | 51,429 | 0 | 0 | |
Nov 12 2020 | RETA | REATA PHARMACEUTIC ... | WORTLEY MICHAEL D | Chief Legal Officer | Option Exercise | M | 0.00 | 39,184 | 0 | 51,429 | |
Nov 12 2020 | RETA | REATA PHARMACEUTIC ... | WORTLEY MICHAEL D | Chief Legal Officer | Option Exercise | M | 0.00 | 12,245 | 0 | 12,245 | |
Nov 12 2020 | RETA | REATA PHARMACEUTIC ... | WORTLEY MICHAEL D | Chief Legal Officer | Option Exercise | M | 17.43 | 39,184 | 682,977 | 0 | |
Nov 12 2020 | RETA | REATA PHARMACEUTIC ... | WORTLEY MICHAEL D | Chief Legal Officer | Option Exercise | M | 11.00 | 12,245 | 134,695 | 0 | |
Nov 12 2020 | RETA | REATA PHARMACEUTIC ... | WORTLEY MICHAEL D | Chief Legal Officer | Sell | S | 184.00 | 100 | 18,400 | 0 | 100 to 0 (-100.00 %) |
Nov 12 2020 | RETA | REATA PHARMACEUTIC ... | WORTLEY MICHAEL D | Chief Legal Officer | Sell | S | 182.64 | 410 | 74,883 | 100 | 510 to 100 (-80.39 %) |
Nov 12 2020 | RETA | REATA PHARMACEUTIC ... | WORTLEY MICHAEL D | Chief Legal Officer | Sell | S | 182.06 | 2,100 | 382,323 | 510 | 2.6 K to 510 (-80.46 %) |
Nov 12 2020 | RETA | REATA PHARMACEUTIC ... | WORTLEY MICHAEL D | Chief Legal Officer | Sell | S | 180.93 | 7,971 | 1,442,159 | 2,610 | 10.6 K to 2.6 K (-75.33 %) |
Nov 12 2020 | RETA | REATA PHARMACEUTIC ... | WORTLEY MICHAEL D | Chief Legal Officer | Sell | S | 180.24 | 10,552 | 1,901,916 | 10,581 | 21.1 K to 10.6 K (-49.93 %) |
Nov 12 2020 | RETA | REATA PHARMACEUTIC ... | WORTLEY MICHAEL D | Chief Legal Officer | Sell | S | 179.05 | 16,608 | 2,973,623 | 21,133 | 37.7 K to 21.1 K (-44.01 %) |
Nov 12 2020 | RETA | REATA PHARMACEUTIC ... | WORTLEY MICHAEL D | Chief Legal Officer | Sell | S | 178.10 | 9,386 | 1,671,617 | 37,741 | 47.1 K to 37.7 K (-19.92 %) |
Nov 12 2020 | RETA | REATA PHARMACEUTIC ... | WORTLEY MICHAEL D | Chief Legal Officer | Sell | S | 177.24 | 2,190 | 388,157 | 47,127 | 49.3 K to 47.1 K (-4.44 %) |
Nov 12 2020 | RETA | REATA PHARMACEUTIC ... | WORTLEY MICHAEL D | Chief Legal Officer | Sell | S | 175.94 | 2,112 | 371,592 | 49,317 | 51.4 K to 49.3 K (-4.11 %) |
Nov 12 2020 | RETA | REATA PHARMACEUTIC ... | WORTLEY MICHAEL D | Chief Legal Officer | Buy | C | 0.00 | 51,429 | 0 | 51,429 | 0 to 51.4 K |
Nov 10 2020 | RETA | REATA PHARMACEUTIC ... | Meyer Colin John | Chief Research Offi ... | Sell | S | 175.00 | 25,000 | 4,375,000 | 72,000 | 97 K to 72 K (-25.77 %) |
Nov 10 2020 | RETA | REATA PHARMACEUTIC ... | Huff James Warren | Chief Executive Off ... | Sell | S | 175.00 | 64,970 | 11,369,756 | 0 | 65 K to 0 (-100.00 %) |
Nov 10 2020 | RETA | REATA PHARMACEUTIC ... | Huff James Warren | Chief Executive Off ... | Sell | S | 175.06 | 16,687 | 2,921,291 | 64,970 | 81.7 K to 65 K (-20.44 %) |
Nov 10 2020 | RETA | REATA PHARMACEUTIC ... | Bir Dawn Carter | Chief Commercial Of ... | Option Exercise | C | 0.00 | 60,000 | 0 | 0 | |
Nov 10 2020 | RETA | REATA PHARMACEUTIC ... | Bir Dawn Carter | Chief Commercial Of ... | Option Exercise | M | 0.00 | 60,000 | 0 | 60,000 | |
Nov 10 2020 | RETA | REATA PHARMACEUTIC ... | Bir Dawn Carter | Chief Commercial Of ... | Option Exercise | M | 21.05 | 60,000 | 1,263,000 | 90,000 | |
Nov 10 2020 | RETA | REATA PHARMACEUTIC ... | Bir Dawn Carter | Chief Commercial Of ... | Sell | S | 175.00 | 30,000 | 5,250,000 | 0 | 30 K to 0 (-100.00 %) |
Nov 10 2020 | RETA | REATA PHARMACEUTIC ... | Bir Dawn Carter | Chief Commercial Of ... | Sell | S | 150.01 | 30,000 | 4,500,300 | 30,000 | 60 K to 30 K (-50.00 %) |
Nov 10 2020 | RETA | REATA PHARMACEUTIC ... | Bir Dawn Carter | Chief Commercial Of ... | Buy | C | 0.00 | 60,000 | 0 | 60,000 | 0 to 60 K |
Aug 14 2020 | RETA | REATA PHARMACEUTIC ... | Soni Manmeet Singh | COO and CFO | Buy | P | 100.19 | 1,000 | 100,190 | 3,000 | 2 K to 3 K (+50.00 %) |
Aug 14 2020 | RETA | REATA PHARMACEUTIC ... | Soni Manmeet Singh | COO and CFO | Buy | P | 100.22 | 2,000 | 200,440 | 2,000 | 0 to 2 K |
Aug 04 2020 | RETA | REATA PHARMACEUTIC ... | Edwards Martin | Director | Option Exercise | A | 149.29 | 6,300 | 940,527 | 6,300 | |
Aug 04 2020 | RETA | REATA PHARMACEUTIC ... | Edwards Martin | Director | Option Exercise | A | 149.29 | 10,000 | 1,492,900 | 10,000 | |
Jun 22 2020 | RETA | REATA PHARMACEUTIC ... | McGaughy R Kent Jr | Option Exercise | A | 130.92 | 699 | 91,513 | 699 | ||
Jun 22 2020 | RETA | REATA PHARMACEUTIC ... | McGaughy R Kent Jr | Option Exercise | A | 130.92 | 6,300 | 824,796 | 6,300 | ||
Jun 22 2020 | RETA | REATA PHARMACEUTIC ... | ROSE WILLIAM | Director | Option Exercise | A | 130.92 | 760 | 99,499 | 760 | |
Jun 22 2020 | RETA | REATA PHARMACEUTIC ... | ROSE WILLIAM | Director | Option Exercise | A | 130.92 | 6,300 | 824,796 | 6,300 | |
Jun 22 2020 | RETA | REATA PHARMACEUTIC ... | Nielsen Jack | Director | Option Exercise | A | 130.92 | 1,278 | 167,316 | 1,278 | |
Jun 22 2020 | RETA | REATA PHARMACEUTIC ... | Nielsen Jack | Director | Option Exercise | A | 130.92 | 6,300 | 824,796 | 6,300 | |
Jun 22 2020 | RETA | REATA PHARMACEUTIC ... | McClellan William D. Jr. | Director | Option Exercise | A | 130.92 | 6,300 | 824,796 | 6,300 | |
Jun 22 2020 | RETA | REATA PHARMACEUTIC ... | Bass James Edward | Director | Option Exercise | A | 130.92 | 821 | 107,485 | 821 | |
Jun 22 2020 | RETA | REATA PHARMACEUTIC ... | Bass James Edward | Director | Option Exercise | A | 130.92 | 6,300 | 824,796 | 6,300 | |
Jun 01 2020 | RETA | REATA PHARMACEUTIC ... | Castellanos Elaine | VP, Chief Accountin ... | Option Exercise | C | 0.00 | 2,000 | 0 | 0 | |
Jun 01 2020 | RETA | REATA PHARMACEUTIC ... | Castellanos Elaine | VP, Chief Accountin ... | Option Exercise | M | 0.00 | 2,000 | 0 | 2,000 | |
Jun 01 2020 | RETA | REATA PHARMACEUTIC ... | Castellanos Elaine | VP, Chief Accountin ... | Option Exercise | M | 11.00 | 2,000 | 22,000 | 6,434 | |
Jun 01 2020 | RETA | REATA PHARMACEUTIC ... | Castellanos Elaine | VP, Chief Accountin ... | Sell | S | 143.97 | 2,000 | 287,940 | 15,146 | 17.1 K to 15.1 K (-11.66 %) |
Jun 01 2020 | RETA | REATA PHARMACEUTIC ... | Castellanos Elaine | VP, Chief Accountin ... | Buy | C | 0.00 | 2,000 | 0 | 17,146 | 15.1 K to 17.1 K (+13.20 %) |
Mar 02 2020 | RETA | REATA PHARMACEUTIC ... | Castellanos Elaine | VP, Chief Accountin ... | Option Exercise | C | 0.00 | 2,000 | 0 | 0 | |
Mar 02 2020 | RETA | REATA PHARMACEUTIC ... | Castellanos Elaine | VP, Chief Accountin ... | Option Exercise | M | 0.00 | 2,000 | 0 | 2,000 | |
Mar 02 2020 | RETA | REATA PHARMACEUTIC ... | Castellanos Elaine | VP, Chief Accountin ... | Option Exercise | M | 11.00 | 2,000 | 22,000 | 8,434 | |
Mar 02 2020 | RETA | REATA PHARMACEUTIC ... | Castellanos Elaine | VP, Chief Accountin ... | Sell | S | 194.32 | 2,000 | 388,640 | 15,146 | 17.1 K to 15.1 K (-11.66 %) |
Mar 02 2020 | RETA | REATA PHARMACEUTIC ... | Castellanos Elaine | VP, Chief Accountin ... | Buy | C | 0.00 | 2,000 | 0 | 17,146 | 15.1 K to 17.1 K (+13.20 %) |
Jan 06 2020 | RETA | REATA PHARMACEUTIC ... | WORTLEY MICHAEL D | Chief Legal Officer | Option Exercise | A | 207.20 | 24,000 | 4,972,800 | 24,000 | |
Jan 06 2020 | RETA | REATA PHARMACEUTIC ... | Wilson Jason Douglas | Executive VP of Ope ... | Option Exercise | A | 207.20 | 15,000 | 3,108,000 | 15,000 | |
Jan 06 2020 | RETA | REATA PHARMACEUTIC ... | Soni Manmeet Singh | Chief Financial Off ... | Option Exercise | A | 207.20 | 25,000 | 5,180,000 | 25,000 | |
Jan 06 2020 | RETA | REATA PHARMACEUTIC ... | Meyer Colin John | Chief Medical Offic ... | Option Exercise | A | 207.20 | 25,000 | 5,180,000 | 25,000 | |
Jan 06 2020 | RETA | REATA PHARMACEUTIC ... | Huff James Warren | Chief Executive Off ... | Option Exercise | A | 207.20 | 40,000 | 8,288,000 | 40,000 | |
Jan 06 2020 | RETA | REATA PHARMACEUTIC ... | Castellanos Elaine | VP, Chief Accountin ... | Option Exercise | A | 207.20 | 15,000 | 3,108,000 | 15,000 | |
Jan 06 2020 | RETA | REATA PHARMACEUTIC ... | Bir Dawn Carter | Chief Commercial Of ... | Option Exercise | A | 207.20 | 24,000 | 4,972,800 | 24,000 | |
Dec 17 2019 | RETA | REATA PHARMACEUTIC ... | Wilson Jason Douglas | Executive VP of Ope ... | Option Exercise | C | 0.00 | 5,600 | 0 | 13,227 | |
Dec 17 2019 | RETA | REATA PHARMACEUTIC ... | Wilson Jason Douglas | Executive VP of Ope ... | Option Exercise | C | 0.00 | 10,000 | 0 | 18,827 | |
Dec 17 2019 | RETA | REATA PHARMACEUTIC ... | Wilson Jason Douglas | Executive VP of Ope ... | Option Exercise | M | 0.00 | 10,000 | 0 | 28,827 | |
Dec 17 2019 | RETA | REATA PHARMACEUTIC ... | Wilson Jason Douglas | Executive VP of Ope ... | Option Exercise | M | 11.00 | 10,000 | 110,000 | 34,881 | |
Dec 17 2019 | RETA | REATA PHARMACEUTIC ... | Wilson Jason Douglas | Executive VP of Ope ... | Sell | S | 207.48 | 400 | 82,992 | 12,950 | 13.4 K to 13 K (-3.00 %) |
Dec 17 2019 | RETA | REATA PHARMACEUTIC ... | Wilson Jason Douglas | Executive VP of Ope ... | Sell | S | 206.89 | 400 | 82,754 | 13,350 | 13.8 K to 13.4 K (-2.91 %) |
Dec 17 2019 | RETA | REATA PHARMACEUTIC ... | Wilson Jason Douglas | Executive VP of Ope ... | Sell | S | 205.08 | 200 | 41,015 | 13,750 | 14 K to 13.8 K (-1.43 %) |
Dec 17 2019 | RETA | REATA PHARMACEUTIC ... | Wilson Jason Douglas | Executive VP of Ope ... | Sell | S | 204.54 | 1,480 | 302,722 | 13,950 | 15.4 K to 14 K (-9.59 %) |
Dec 17 2019 | RETA | REATA PHARMACEUTIC ... | Wilson Jason Douglas | Executive VP of Ope ... | Sell | S | 203.60 | 2,320 | 472,342 | 15,430 | 17.8 K to 15.4 K (-13.07 %) |
Dec 17 2019 | RETA | REATA PHARMACEUTIC ... | Wilson Jason Douglas | Executive VP of Ope ... | Sell | S | 202.51 | 3,400 | 688,534 | 17,750 | 21.2 K to 17.8 K (-16.08 %) |
Dec 17 2019 | RETA | REATA PHARMACEUTIC ... | Wilson Jason Douglas | Executive VP of Ope ... | Sell | S | 201.65 | 1,300 | 262,146 | 21,150 | 22.5 K to 21.2 K (-5.79 %) |
Dec 17 2019 | RETA | REATA PHARMACEUTIC ... | Wilson Jason Douglas | Executive VP of Ope ... | Sell | S | 200.17 | 500 | 100,086 | 22,450 | 23 K to 22.5 K (-2.18 %) |
Dec 17 2019 | RETA | REATA PHARMACEUTIC ... | Wilson Jason Douglas | Executive VP of Ope ... | Buy | C | 0.00 | 5,600 | 0 | 22,950 | 17.4 K to 23 K (+32.28 %) |
Dec 17 2019 | RETA | REATA PHARMACEUTIC ... | Wilson Jason Douglas | Executive VP of Ope ... | Buy | C | 0.00 | 10,000 | 0 | 17,350 | 7.4 K to 17.4 K (+136.05 %) |
Dec 17 2019 | RETA | REATA PHARMACEUTIC ... | Meyer Colin John | Chief Medical Offic ... | Option Exercise | C | 0.00 | 69,828 | 0 | 59,779 | |
Dec 17 2019 | RETA | REATA PHARMACEUTIC ... | Meyer Colin John | Chief Medical Offic ... | Buy | C | 0.00 | 69,828 | 0 | 97,000 | 27.2 K to 97 K (+256.99 %) |
Dec 16 2019 | RETA | REATA PHARMACEUTIC ... | Traweek James W JR | Option Exercise | C | 0.00 | 30,478 | 0 | 0 | ||
Dec 16 2019 | RETA | REATA PHARMACEUTIC ... | Traweek James W JR | Buy | C | 0.00 | 30,478 | 0 | 33,217 | 2.7 K to 33.2 K (+1,112.74 %) | |
Dec 16 2019 | RETA | REATA PHARMACEUTIC ... | McGaughy R Kent Jr | Option Exercise | C | 0.00 | 30,478 | 0 | 0 | ||
Dec 16 2019 | RETA | REATA PHARMACEUTIC ... | McGaughy R Kent Jr | Buy | C | 0.00 | 30,478 | 0 | 33,217 | 2.7 K to 33.2 K (+1,112.74 %) | |
Dec 05 2019 | RETA | REATA PHARMACEUTIC ... | ROSE WILLIAM | Director | Option Exercise | C | 0.00 | 15,869 | 0 | 0 | |
Dec 05 2019 | RETA | REATA PHARMACEUTIC ... | ROSE WILLIAM | Director | Sell | S | 215.32 | 2,000 | 430,640 | 19,795 | 21.8 K to 19.8 K (-9.18 %) |
Dec 05 2019 | RETA | REATA PHARMACEUTIC ... | ROSE WILLIAM | Director | Sell | S | 211.27 | 2,000 | 422,540 | 21,795 | 23.8 K to 21.8 K (-8.41 %) |
Dec 05 2019 | RETA | REATA PHARMACEUTIC ... | ROSE WILLIAM | Director | Sell | S | 210.00 | 2,000 | 420,000 | 23,795 | 25.8 K to 23.8 K (-7.75 %) |
Dec 05 2019 | RETA | REATA PHARMACEUTIC ... | ROSE WILLIAM | Director | Sell | S | 215.89 | 591 | 127,591 | 25,795 | 26.4 K to 25.8 K (-2.24 %) |
Dec 05 2019 | RETA | REATA PHARMACEUTIC ... | ROSE WILLIAM | Director | Sell | S | 210.00 | 2,000 | 420,000 | 26,386 | 28.4 K to 26.4 K (-7.05 %) |
Dec 05 2019 | RETA | REATA PHARMACEUTIC ... | ROSE WILLIAM | Director | Sell | S | 200.00 | 600 | 120,000 | 28,386 | 29 K to 28.4 K (-2.07 %) |
Dec 05 2019 | RETA | REATA PHARMACEUTIC ... | ROSE WILLIAM | Director | Sell | S | 205.10 | 400 | 82,040 | 28,986 | 29.4 K to 29 K (-1.36 %) |
Dec 05 2019 | RETA | REATA PHARMACEUTIC ... | ROSE WILLIAM | Director | Buy | C | 0.00 | 15,869 | 0 | 29,386 | 13.5 K to 29.4 K (+117.40 %) |
Dec 03 2019 | RETA | REATA PHARMACEUTIC ... | Castellanos Elaine | VP, Chief Accountin ... | Option Exercise | C | 0.00 | 2,000 | 0 | 0 | |
Dec 03 2019 | RETA | REATA PHARMACEUTIC ... | Castellanos Elaine | VP, Chief Accountin ... | Option Exercise | M | 0.00 | 2,000 | 0 | 2,000 | |
Dec 03 2019 | RETA | REATA PHARMACEUTIC ... | Castellanos Elaine | VP, Chief Accountin ... | Option Exercise | M | 11.00 | 2,000 | 22,000 | 10,434 | |
Dec 03 2019 | RETA | REATA PHARMACEUTIC ... | Castellanos Elaine | VP, Chief Accountin ... | Sell | S | 194.24 | 2,000 | 388,480 | 15,146 | 17.1 K to 15.1 K (-11.66 %) |
Dec 03 2019 | RETA | REATA PHARMACEUTIC ... | Castellanos Elaine | VP, Chief Accountin ... | Buy | C | 0.00 | 2,000 | 0 | 17,146 | 15.1 K to 17.1 K (+13.20 %) |
Nov 18 2019 | RETA | REATA PHARMACEUTIC ... | Traweek James W JR | Buy | P | 183.00 | 40,218 | 7,359,894 | 3,063,567 | 3 M to 3.1 M (+1.33 %) | |
Nov 18 2019 | RETA | REATA PHARMACEUTIC ... | McGaughy R Kent Jr | Buy | P | 183.00 | 40,218 | 7,359,894 | 3,063,567 | 3 M to 3.1 M (+1.33 %) | |
Nov 18 2019 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 183.00 | 5,464 | 999,912 | 5,464 | 0 to 5.5 K | |
Nov 18 2019 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 183.00 | 27,322 | 4,999,926 | 137,962 | 110.6 K to 138 K (+24.69 %) | |
Nov 18 2019 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 183.00 | 328 | 60,024 | 282,246 | 281.9 K to 282.2 K (+0.12 %) | |
Nov 18 2019 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 183.00 | 7,104 | 1,300,032 | 116,512 | 109.4 K to 116.5 K (+6.49 %) | |
Nov 12 2019 | RETA | REATA PHARMACEUTIC ... | WORTLEY MICHAEL D | Chief Legal Officer | Option Exercise | A | 55.73 | 17,250 | 961,343 | 17,250 | |
Nov 12 2019 | RETA | REATA PHARMACEUTIC ... | WORTLEY MICHAEL D | Chief Legal Officer | Option Exercise | A | 55.73 | 17,250 | 961,343 | 17,250 | |
Nov 12 2019 | RETA | REATA PHARMACEUTIC ... | Wilson Jason Douglas | Executive VP of Ope ... | Option Exercise | A | 55.73 | 17,250 | 961,343 | 17,250 | |
Nov 12 2019 | RETA | REATA PHARMACEUTIC ... | Wilson Jason Douglas | Executive VP of Ope ... | Option Exercise | A | 55.73 | 17,250 | 961,343 | 17,250 | |
Nov 12 2019 | RETA | REATA PHARMACEUTIC ... | Meyer Colin John | Chief Medical Offic ... | Option Exercise | A | 55.73 | 17,750 | 989,208 | 17,750 | |
Nov 12 2019 | RETA | REATA PHARMACEUTIC ... | Meyer Colin John | Chief Medical Offic ... | Option Exercise | A | 55.73 | 17,750 | 989,208 | 17,750 | |
Nov 12 2019 | RETA | REATA PHARMACEUTIC ... | Huff James Warren | Chief Executive Off ... | Option Exercise | A | 55.73 | 57,250 | 3,190,543 | 57,250 |